EUVIMEDEUVIMED entdecken
Open Access

Codelivery of synergistic antimicrobials with polyelectrolyte nanocomplexes to treat bacterial biofilms and lung infections

Joel A Finbloom iD, Preethi Raghavan iD, Michael Kwon, Bhushan N Kharbikar iD, Michelle A Yu iD, Tejal A Desai iD

Science Advances · 20.01.2023 · 9 (3)

DOI: 10.1126/sciadv.ade8039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 20.01.2023. Verfasst von Joel A Finbloom und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Metal Nanoparticles, Pseudomonas Infections, Pneumonia. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial biofilm infections, particularly those of Pseudomonas aeruginosa (PA), have high rates of antimicrobial tolerance and are commonly found in chronic wound and cystic fibrosis lung infections. Combination therapeutics that act synergistically can overcome antimicrobial tolerance; however, the delivery of multiple therapeutics at relevant dosages remains a challenge. We therefore developed a nanoscale drug carrier for antimicrobial codelivery by combining approaches from polyelectrolyte nanocomplex (NC) formation and layer-by-layer electrostatic self-assembly. This strategy led to NC drug carriers loaded with tobramycin antibiotics and antimicrobial silver nanoparticles (AgTob-NCs). AgTob-NCs displayed synergistic enhancements in antimicrobial activity against both planktonic and biofilm PA cultures, with positively charged NCs outperforming negatively charged formulations. NCs were evaluated in mouse models of lung infection, leading to reduced bacterial burden and improved survival outcomes. This approach therefore shows promise for nanoscale therapeutic codelivery to treat recalcitrant bacterial infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal NanoparticlesPseudomonas InfectionsPneumoniaAnimalsMicePolyelectrolytesMicrobial Sensitivity TestsSilverAnti-Bacterial AgentsDrug CarriersBiofilmsPseudomonas aeruginosaLung

Substanzen

PolyelectrolytesSilverAnti-Bacterial AgentsDrug Carriers

Autor:innen und Institutionen

  • Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.
  • Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • School of Engineering, Brown University, Providence, RI, USA.

ORCID-Profile: Joel A Finbloom, Preethi Raghavan, Bhushan N Kharbikar, Michelle A Yu, Tejal A Desai

Zitieren

APA

Finbloom, J. A., Raghavan, P., Kwon, M., Kharbikar, B. N., Yu, M. A., & Desai, T. A. (2023). Codelivery of synergistic antimicrobials with polyelectrolyte nanocomplexes to treat bacterial biofilms and lung infections. Science Advances, 9(3). https://doi.org/10.1126/sciadv.ade8039

Vancouver

Finbloom JA, Raghavan P, Kwon M, Kharbikar BN, Yu MA, Desai TA. Codelivery of synergistic antimicrobials with polyelectrolyte nanocomplexes to treat bacterial biofilms and lung infections. Science Advances. 2023;9(3). doi:10.1126/sciadv.ade8039

BibTeX
@article{Finbloom2023,
  author = {Finbloom, Joel A and Raghavan, Preethi and Kwon, Michael and Kharbikar, Bhushan N and Yu, Michelle A and Desai, Tejal A},
  title = {Codelivery of synergistic antimicrobials with polyelectrolyte nanocomplexes to treat bacterial biofilms and lung infections},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {3},
  doi = {10.1126/sciadv.ade8039}
}
Kostenlos starten →